Page 6 - Morphosys Papiere Linked News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Morphosys papiere linked. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Morphosys Papiere Linked Today - Breaking & Trending Today

Short Interest in MorphoSys AG (NASDAQ:MOR) Increases By 255.2%

MorphoSys AG (NASDAQ:MOR – Get Free Report) was the recipient of a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 1,290,000 shares, a growth of 255.2% from the November 15th total of 363,200 shares. Based on an average daily trading volume, of 767,600 shares, […] ....

United States , Leerink Partnrs , Jpmorgan Chase Co , Morgan Stanley , Virtu Financial , Goldman Sachs Group , Envestnet Asset Management Inc , Qube Research Technologies Ltd , Get Free Report , Technologies Ltd , Envestnet Asset Management , Morphosys Daily , Nasdaq Mor ,

EQS-Adhoc: Ad hoc: MorphoSys AG Launches Cash Capital Increase by way of Accelerated Bookbuilding Process - adhoc - Börsennachrichten

EQSAdhoc MorphoSys AG Key word Capital Increase Ad hoc MorphoSys AG Launches Cash Capital Increase by way of Accelerated Bookbuilding Process 13Dec2023 2201 CETCEST Disclosure of an inside informatio ....

United States , United Kingdom , Julia Neugebauer , Financial Services , Distribution Services , Frankfurt Stock Exchange , European Parliament , Exchange Commission , Cash Capital Increase , Accelerated Bookbuilding Process , Accelerated Bookbuilding , Management Board , Supervisory Board , New Shares , New Share , Prime Standard , Frankfurt Stock , Securities Act , Markets Act , Financial Promotion , Relevant Persons , European Economic Area , Prospectus Regulation , Securities Act , Prospectus Regulation , Qualified Investors ,

MorphoSys (NASDAQ:MOR) Stock Rating Reaffirmed by Leerink Partnrs

Leerink Partnrs reiterated their market perform rating on shares of MorphoSys (NASDAQ:MOR – Free Report) in a research note published on Wednesday morning, PriceTargets.com reports. Leerink Partnrs also issued estimates for MorphoSys’ FY2026 earnings at ($0.78) EPS. A number of other research analysts have also recently weighed in on MOR. Morgan Stanley raised MorphoSys from […] ....

United States , Leerink Partnrs , Morgan Stanley , Blackrock Inc , Virtu Financial , Qube Research Technologies Ltd , Jpmorgan Chase Co , Goldman Sachs Group , Free Report , Get Free Report , Technologies Ltd , Morphosys Daily , Nasdaq Mor , Reiterated Rating ,

Leerink Partnrs Reiterates "Market Perform" Rating for MorphoSys (NASDAQ:MOR)

Leerink Partnrs reissued their market perform rating on shares of MorphoSys (NASDAQ:MOR – Free Report) in a research report report published on Wednesday morning, PriceTargets.com reports. Leerink Partnrs also issued estimates for MorphoSys’ FY2026 earnings at ($0.78) EPS. Other research analysts have also issued research reports about the company. The Goldman Sachs Group cut their […] ....

United States , Leerink Partnrs , Morgan Stanley , Citadel Advisors , Virtu Financial , Jpmorgan Chase Co , Optiver Holding , Goldman Sachs Group , T Rowe Price Investment Management Inc , Free Report , Get Free Report , Price Investment Management , Morphosys Daily , Nasdaq Mor , Reiterated Rating ,

MorphoSys (NASDAQ:MOR) Rating Reiterated by Leerink Partnrs

MorphoSys (NASDAQ:MOR – Get Free Report)‘s stock had its “market perform” rating reissued by analysts at Leerink Partnrs in a research note issued to investors on Wednesday, PriceTargets.com reports. Leerink Partnrs also issued estimates for MorphoSys’ FY2026 earnings at ($0.78) EPS. A number of other equities research analysts have also weighed in on the stock. […] ....

United States , Leerink Partnrs , Morgan Stanley , Envestnet Asset Management Inc , Qube Research Technologies Ltd , Virtu Financial , Goldman Sachs Group , Morphosys Company Profile , Jpmorgan Chase Co , Get Free Report , Technologies Ltd , Envestnet Asset Management , Morphosys Daily , Nasdaq Mor , Reiterated Rating ,